CD133⁺⁺ cells as a therapeutic target for kidney diseases

Author： Bussolati Benedetta Collino Federica Camussi Giovanni

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.2, 2012-02, pp. : 157-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD4⁺CD25⁺ regulatory T cells: a therapeutic target for liver diseases

By Zheng Ming-Hua Gu Dian-Na Braddock Martin Leishman Andrew J Jin Chang Wen Jin-Sheng Gong Yue-Wen Chen Yong-Ping

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 313-326

Informa Healthcare

Access to resources Recommend Favorite

B cells as a therapeutic target in autoimmune diseases

By Park Yong Wook Pryshchep Sergey Seyler Thorsten M Goronzy Jörg J Weyand Cornelia M

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 431-445

Informa Healthcare

Access to resources Recommend Favorite

CD133 as a target for colon cancer

By Catalano Veronica Di Franco Simone Iovino Flora Dieli Francesco Stassi Giorgio Todaro Matilde

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 3, 2012-03 ,pp. : 259-267

Informa Healthcare

Access to resources Recommend Favorite

microRNA-133: Expression, Function and Therapeutic Potential in Muscle Diseases and Cancer

Current Drug Targets, Vol. 15, Iss. 9, 2014-08 ,pp. : 817-828

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutic targets in paediatric kidney diseases

By Sariola H. Jalanko H.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 29-38

Informa Healthcare

Access to resources Recommend Favorite